Arbutus Biopharma (ABUS) Price to Sales (2013 - 2026)
Arbutus Biopharma's (ABUS) Price to Sales came in at 5.22 for Q2 2026, down 86.4% from 38.41 a year earlier but up 12.8% from the prior quarter.
Powered by 
Analysis
Arbutus Biopharma (ABUS) Price to Sales (2013 - 2026) Analysis & Trends
For FY2025, Arbutus Biopharma's Price to Sales stood at 65.76, down 34.7% from FY2024.
- In prior years, Arbutus Biopharma's Price to Sales was 100.66 in FY2024 (+330.0%), 23.41 in FY2023 (+149.0%), 9.40 in FY2022 (-75.0%) and 37.61 in FY2021 (-18.3%).
- Quarterly Price to Sales has run from a low of 4.63 in Q1 2026 to a high of 108.18 in Q3 2024 over five years.
- On a year-over-year basis, Price to Sales has declined in each of the last five quarters, with growth averaging 104.1% over the last eight quarters.
- The strongest year-over-year quarter for Price to Sales in the past five years was Q3 2024, with growth of 606.8%; the weakest was Q1 2026, with a decline of 95.6%.
- According to Business Quant data, Price to Sales for the three prior quarters was 4.63 (Q1 2026), 65.76 (Q4 2025) and 59.67 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Arbutus Biopharma | 944.69 Mn | 571.67 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.22 |
| Mar 31, 2026 | 4.63 |
| Dec 31, 2025 | 65.76 |
| Sep 30, 2025 | 59.67 |
| Jun 30, 2025 | 38.41 |
| Mar 31, 2025 | 104.37 |
| Dec 31, 2024 | 100.66 |
| Sep 30, 2024 | 108.18 |
| Jun 30, 2024 | 57.97 |
| Mar 31, 2024 | 35.80 |
| Dec 31, 2023 | 23.41 |
| Sep 30, 2023 | 15.31 |
| Jun 30, 2023 | 16.31 |
| Mar 31, 2023 | 15.10 |
| Dec 31, 2022 | 9.40 |
| Sep 30, 2022 | 8.11 |
| Jun 30, 2022 | 12.08 |
| Mar 31, 2022 | 20.66 |
| Dec 31, 2021 | 37.61 |
| Sep 30, 2021 | 46.52 |
API Access
Arbutus Biopharma Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=ABUS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "ABUS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=ABUS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();